Skip to content

SWEET: Postpartum Navigation After GDM

SWEET: Sustaining Women's Engagement and Enabling Transitions After Gestational Diabetes Mellitus

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04583839
Acronym
SWEET
Enrollment
40
Registered
2020-10-12
Start date
2020-12-01
Completion date
2024-01-31
Last updated
2024-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes, Preventive Care / Anticipatory Guidance, Retention in Care, Postpartum Health, Lifestyle Modification

Brief summary

This study is a pilot assessment of Sustaining Women's Engagement and Enabling Transitions after GDM (SWEET), a GDM-focused intervention that will apply barrier-reduction patient navigation strategies to improve health after a pregnancy with gestational diabetes mellitus. The investigators aim to determine, via a randomized controlled trial of 40 women who have had GDM, whether those who receive the navigation intervention have improved diabetes-related health at 1 year after birth compared to those who receive usual care. The SWEET intervention will provide GDM-specific, individualized navigation services that leverage existing clinical infrastructure, including logistical support, psychosocial support, and health education, through 1-year postpartum. Participants will undergo surveys, interviews, and medical record review at multiple time points. The investigators will also conduct qualitative interviews with clinical providers.

Detailed description

Gestational diabetes mellitus (GDM) poses a substantial long-term health burden to women due to the 7-fold increased risk of developing type 2 diabetes mellitus (T2DM) and other cardiovascular disorders. Yet, there are many gaps in the transition period after GDM, which is a particularly critical time due to enhanced motivation and access. Nevertheless, a minority of women receive postpartum screening for dysglycemia or have successful transition to primary care. Although T2DM prevention interventions can be successful, they cannot be deployed without retention and engagement in care. Addressing the unique barriers experienced by postpartum women requires innovative models of health care delivery to promote prevention of T2DM after GDM. One potential intervention with demonstrated successes in other arenas is patient navigation, a barrier-focused, longitudinal, patient-centered intervention that offers support for a defined set of health services. This protocol is to perform a pilot assessment of Sustaining Women's Engagement and Enabling Transitions after GDM (SWEET), a GDM-focused intervention that will apply barrier-reduction patient navigation strategies to improve health after a pregnancy with GDM. The investigators aim to determine, via a randomized controlled trial of 40 women who have had GDM, whether those who receive the SWEET navigation intervention have improved diabetes-related health at 1 year after birth compared to those who receive usual care. In order to promote self-efficacy, enhance access, and sustain long-term engagement, the SWEET intervention will provide GDM-specific, individualized navigation services that leverage existing clinical infrastructure, including logistical support, psychosocial support, and health education, through 1-year postpartum. Aim 1 will evaluate whether clinical (weight, glycemic control, abdominal circumference, and blood pressure), health services (postpartum and primary care visit attendance), and patient-reported (diabetes self-efficacy, activation, and T2DM risk perception) outcomes differ in women exposed to SWEET versus usual care. Aim 2 will evaluate feasibility and acceptability. This proposal will generate key data for the conduct of a full-scale trial of a GDM-specific postpartum patient navigation program that will address critical questions about long-term maternal health and T2DM prevention. SWEET bridges the chasm between care during pregnancy - focused on improving the health of the pregnant woman and her offspring - and long-term women's health care - focused on chronic disease management and preventive health. The long-term goals are to understand how to optimize long-term health after GDM in order to prevent or ameliorate the effects of T2DM beyond the perinatal period.

Interventions

SWEET is a GDM-focused intervention that will apply barrier-reduction patient navigation strategies to improve health after a pregnancy with GDM. Women in SWEET will receive GDM-specific, tapered, individualized navigation services, including logistical support, psychosocial support, and patient education, through 1-year postpartum.

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

There will be two cohorts. One cohort will be provided intensive, individualized patient navigation services through one year postpartum, with a focus on diabetes prevention. The second cohort will receive usual care.

Eligibility

Sex/Gender
FEMALE
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patient Participants: Inclusion Criteria: * Pregnancy delivering at or after 30 weeks of gestation, regardless of neonatal outcome * Gestational diabetes mellitus, treatment of any modality * English- or Spanish- speaker * Age 16 or greater * Established patient at the Northwestern Medicine obstetrics and gynecology practices

Exclusion criteria

* Intent to transfer prenatal care to an outside institution or leave Chicago region * Pre-gestational diabetes mellitus * Weight loss during pregnancy * History of bariatric surgery * Prior enrollment in SWEET * Enrollment in a concurrent research study that poses a potential conflict to the aims of SWEET or the other study Health care provider participants: Inclusion Criteria: * Age 18 or greater * English-speaking * Obstetrician or advanced practitioner who has provided postpartum care to a participating SWEET participant OR primary care provider who has provided primary care to a participating SWEET participant

Design outcomes

Primary

MeasureTime frameDescription
Postpartum weight retention1 year postpartumDifference between 1) preconception weight and 2) weight at 1 year postpartum,

Secondary

MeasureTime frameDescription
Postpartum diabetes screening completion4-12 weeks postpartumNumber of women with completion of a 2-hour oral glucose tolerance test by 12 weeks postpartum.
Postpartum diabetes screening result4-12 weeks postpartumResult of postpartum OGTT.
Abdominal circumference4-12 weeks and 1 year postpartumAbdominal circumference at any time point in the first year after giving birth.
Blood pressure4-12 weeks and 1 year postpartumBlood pressure at any time point in the first year after giving birth and proportion with hypertension.
Postpartum visit attendance4-12 weeks postpartumAttendance at a comprehensive postpartum care visit by 12 weeks postpartum.
Assessment of postpartum glycemic control1 year postpartumNumber of women who complete any measure of glycemic control (fasting glucose, random glucose, and/or hemoglobin A1c) by 1 year postpartum.
Postpartum transition to primary care1 year postpartumNumber of women with appointment made and kept for primary care by 1 year postpartum.
Diabetes self-efficacy4-12 weeks and 1 year postpartumDiabetes Empowerment Scale (DES)- Minimum score is 1, and maximum score is 5. Higher scores indicate greater levels of diabetes self-efficacy.
Patient activation4-12 weeks and 1 year postpartumPatient Activation Measure (PAM)- Patient knowledge, skill, and confidence for managing one's own health and healthcare. Minimum score is 1, and maximum score is 100. Higher scores indicate higher activation levels in self-management.
Diabetes risk perception4-12 weeks and 1 year postpartumRisk Perception Survey for Developing Diabetes (RPS-DD)- adapted for women with gestational diabetes- Scores are averaged with higher scores indicating a greater personal control to prevent development of DM. Minimum score of 1, and maximum score of 5. Higher scores indicate greater personal control beliefs.

Other

MeasureTime frameDescription
Participant experiences and perspectives on GDM4-12 weeks and 1 year postpartumQualitative feedback on experience with the GDM diagnosis, barriers to obtaining postpartum GDM-related care, and barriers and facilitators of the primary care transition.
Patient experiences with navigation4-12 weeks and 1 year postpartumParticipants who are randomized to receive navigation will complete in-depth interviews about experiences with the program and areas for improvement.
Health care providers experiences with SWEETThrough completion of study, an average of 2 yearsHealth care providers whose patients participate in the trial will undergo in-depth interviews about provider perceptions of the program, barriers to providing optimal care for women who have had GDM, the methods by which providers and the health care system can adopt postpartum care recommendations, and how to optimize SWEET for future study.
Patient satisfaction with logistical aspects of navigation4-12 weeks and 1 year postpartumPatient Satisfaction with Logistical Aspects of Navigation (PSN-L)- Participants randomized to navigation will complete surveys designed to understand their logistical experiences with patient navigation. Minimum score is 0, and maximum score is 78. Higher scores indicate higher levels of satisfaction.
Patient satisfaction with interpersonal relationship with navigator4-12 weeks and 1 year postpartumPatient Satisfaction with Interpersonal Relationship with Navigator (PSN-I)- Participants randomized to navigation will complete surveys designed to understand their interpersonal experiences with patient navigation. Minimum score is 0, and maximum score is 45. Higher scores indicate higher levels of satisfaction.
Proportion of eligible participants who enrollThrough completion of study, an average of 2 yearsProportion of eligible participants who enroll will be defined as the proportion of women who enroll out of all approached, eligible women.
Recruitment rateThrough completion of study, an average of 2 yearsRecruitment rate will be defined as the number of women successfully enrolled per week during the study, using mean or median to illustrate the variation of the numbers.
Time to enrollmentThrough completion of study, an average of 2 yearsTime to enrollment will be defined as the number of months to enroll target sample size.
Dropout rateThrough completion of study, an average of 2 yearsDropout rate will be defined as the number of enrolled women who drop out of study participation during the 1-year follow-up per week.
Retention rateThrough completion of study, an average of 2 yearsRetention rate will be defined as the proportion of enrolled women who successfully complete all study visits during 1-year follow-up period.
Participant adherence with navigationThrough completion of study, an average of 2 yearsThe participant adherence (engagement rate) outcomes will be calculated both as a proportion (percent of navigator-attempted contacts with response) and count (number of navigator-attempted contacts with response) among participants randomized to navigation. Feasibility targets will be defined as 80% recruitment, retention, and adherence rates. Targets are set at 80% based on prior literature using this threshold to represent greater engagement.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026